HPC Offered for PRESERVE Expansion
Recruiting
Observational Study
Bone Marrow Transplant (BMT)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 12 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10 (estimated)
- Sponsor
- Ossium Health, Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Patients aged 12-80 may be eligible\* to receive bone marrow for transplantation through the Ossium HOPE Program if:
Their treating physician determined they are eligible for allogeneic bone marrow transplant Their treating physician determined that the potential benefit outwei…
Contacts
Preethi Prasad, Senior Director Clinical Operations
415-513-5535
preethi.prasad@ossiumhealth.com
CONTACT